Global Osteoporosis Diagnostics Market US$ 395 Million by 2021

Osteoporosis disease is characterized by thinning and deterioration of bone tissue with loss of calcification and density, and it can progress over time. Women and older adults are more at risk for developing osteoporosis. Heredity, low body weight, and chronic use of certain medications (such as steroids) are also risk factors for the disease.

Visit global osteoporosis diagnostics market by product type (bone densitometry systems, and bone remodeling biochemical marker tests), by geography and forecast 2017-2021 at https://www.ihealthcareanalyst.com/report/osteoporosis-diagnostics-market/

The global osteoporosis diagnostics market research report provides market size (Revenue US$ Million 2014 to 2021), market share analysis, growth trends and forecast (CAGR%, 2017 to 2021). The global osteoporosis diagnostics market research report is further segmented by geography into North America (U.S., Canada), Latin America (Brazil, Mexico, Rest of LA), Europe (U.K., Germany, France, Italy, Spain, Rest of EU), Asia Pacific (Japan, China, India, Rest of APAC), and Rest of the World. In addition, the global osteoporosis diagnostics market report provides the detailed market landscape (market drivers, restraints, opportunities), market attractiveness analysis, and market profitability analysis by key products and regions or countries. The report also tracks the major competitors operating in the global market by company overview, financial snapshot, major products, technologies, services offered and recent developments.

Major players operating in the global osteoporosis diagnostics market and profiled in this report include Alere, Inc., BeamMed, Beckman Coulter, Inc., CompuMed, Inc., Diagnostic Medical Systems, Furuno Electric Company, GE Healthcare, Hitachi Medical Systems, Hologic, Immunodiagnostic Systems Ltd., Orion Diagnostica, Quest Diagnostics, Inc., Quidel Corp., Roche Diagnostics, Sectra AB, and Swissray International, Inc.

1. Product Type
1.1. Bone Densitometry Systems
1.2. Bone Remodeling Biochemical Marker Tests

2. Geography
2.1. North America (U.S., Canada)
2.2. Latin America (Brazil, Mexico, Rest of LA)
2.3. Europe (U.K., Germany, France, Italy, Spain, Rest of EU)
2.4. Asia Pacific (Japan, China, India, Rest of APAC
2.5. Rest of the World

3. Company Profiles
3.1. Alere, Inc.
3.2. BeamMed
3.3. Beckman Coulter, Inc.
3.4. CompuMed, Inc.
3.5. Diagnostic Medical Systems
3.6. Furuno Electric Company
3.7. GE Healthcare
3.8. Hitachi Medical Systems
3.9. Hologic
3.10. Immunodiagnostic Systems Ltd.
3.11. Orion Diagnostica
3.12. Quest Diagnostics, Inc.
3.13. Quidel Corp.
3.14. Roche Diagnostics
3.15. Sectra AB
3.16. Swissray International, Inc.

To request Table of Contents and Sample Pages of this report visit:
https://www.ihealthcareanalyst.com/report/osteoporosis-diagnostics-market/

Global osteosynthesis devices market type of device used (internal fixation devices – intramedullary rods and nails, screws and plates, spinal fixation devices, wires and pins; external fixation devices – fracture fixation devices, radius fracture, tibia fracture and pelvis fracture fixation devices, bone lengthening devices, etc.), materials used (degradable and non-degradable). https://www.ihealthcareanalyst.com/report/osteosynthesis-devices-market/

Global osteoporosis drugs market by drug classes (bisphosphonates, calcitonin, parathyroid hormone therapy drugs, RANK ligand inhibitors, selective estrogen receptor modulators, etc.), clinical pipeline analysis of phase 1, 2 and 3 drugs (Odanacatib, Romosozumab, etc.). https://www.ihealthcareanalyst.com/report/osteoporosis-drugs-market/

iHealthcareAnalyst, Inc. is a global healthcare market research and consulting company providing market analysis, and competitive intelligence services to global clients. The company publishes syndicate, custom and consulting grade healthcare reports covering animal healthcare, biotechnology, clinical diagnostics, healthcare IT, healthcare services, medical devices, medical equipment, and pharmaceuticals.

In addition to multi-client studies, we offer creative consulting services and conduct proprietary single-client assignments targeted at client’s specific business objectives, information needs, time frame and budget. Please contact us to receive a proposal for a proprietary single-client study.

Ana Aitawa
iHealthcareAnalyst, Inc.
2109, Mckelvey Hill Drive,
Maryland Heights, MO 63043
United States
Email: sales@ihealthcareanalyst.com
https://www.ihealthcareanalyst.com

This release was published on openPR.